Dynavax Technologies
DVAX
#5495
Rank
NZ$2.21 B
Marketcap
NZ$18.85
Share price
-0.64%
Change (1 day)
-13.58%
Change (1 year)

Dynavax Technologies (DVAX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$0.71 Billion

According to Dynavax Technologies 's latest financial reports the company's total liabilities are NZ$0.71 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Dynavax Technologies - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$0.69 B16.45%
2023-12-31NZ$0.59 B-7%
2022-12-31NZ$0.63 B-46.68%
2021-12-31NZ$1.19 B192.93%
2020-12-31NZ$0.40 B1.54%
2019-12-31NZ$0.40 B82.45%
2018-12-31NZ$0.22 B713.62%
2017-12-31NZ$27.08 M-8.39%
2016-12-31NZ$29.56 M-31.53%
2015-12-31NZ$43.18 M-10.51%
2014-12-31NZ$48.25 M116.35%
2013-12-31NZ$22.3 M-26.39%
2012-12-31NZ$30.3 M-30.9%
2011-12-31NZ$43.84 M5.26%
2010-12-31NZ$41.65 M-31.38%
2009-12-31NZ$60.7 M-52.69%
2008-12-31NZ$0.12 B20.87%
2007-12-31NZ$0.10 B214.01%
2006-12-31NZ$33.8 M303.28%
2005-12-31NZ$8.38 M-56.56%
2004-12-31NZ$19.29 M-85.87%
2003-12-31NZ$0.13 B-18.63%
2002-12-31NZ$0.16 B40.72%
2001-12-31NZ$0.11 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Agenus
AGEN
NZ$0.89 B 24.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$19.04 B 2,567.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$134.39 B 18,727.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$64.18 B 8,891.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$118.54 B 16,507.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
NZ$106.08 B 14,761.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$200.16 B 27,941.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$56.43 B 7,806.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
NZ$139.38 B 19,426.73%๐Ÿ‡บ๐Ÿ‡ธ USA